Cardinal Health price target raised to $240 from $230 at Leerink

Leerink analyst Michael Cherny raised the firm’s price target on Cardinal Health (CAH) to $240 from $230 and keeps an Outperform rating on the shares. Following Cardinal’s comments at a competitor conference and guidance raise, the firm updated its model, noting that the guidance raise, for the third consecutive time since being announced at its June investor day, demonstrates continued strength across the business. Even with these increases, the firm added that it thinks there is still plenty of room for upside.